{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:36:43Z","timestamp":1763534203948,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.lana.2021.100131","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:13:21Z","timestamp":1638310401000},"page":"100131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6659-1980","authenticated-orcid":false,"given":"Jancy Andrea","family":"Huertas-Quintero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-4072","authenticated-orcid":false,"given":"Natalia","family":"Losada-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Alberto","family":"Cuellar-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvy Mauricio","family":"Velasco-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2021.100131_bib0001","article-title":"X-Linked Hypophosphatemia","volume":"1","author":"Ruppe","year":"2012","journal-title":"GeneReviews"},{"issue":"5","key":"10.1016\/j.lana.2021.100131_bib0002","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2012-4133","article-title":"Cortical and Trabecular Bone Density in X-Linked Hypophosphatemic Rickets","volume":"98","author":"Cheung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lana.2021.100131_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.lana.2021.100131_bib0004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2265.2010.03919.x","article-title":"Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets","volume":"74","author":"Ruppe","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/cen.13347","article-title":"Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets","volume":"87","author":"Guven","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.lana.2021.100131_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/01.PDR.0000169983.40758.7B","article-title":"A Clinical and Molecular Genetic Study of Hypophosphatemic Rickets in Children","volume":"58","author":"Cho","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.lana.2021.100131_bib0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bone.2015.05.040","article-title":"Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets","volume":"79","author":"Capelli","year":"2015","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.lana.2021.100131_bib0008","doi-asserted-by":"crossref","first-page":"e10190","DOI":"10.1002\/jbm4.10190","article-title":"FGF23, Hypophosphatemia, and Emerging Treatments","volume":"3","author":"Imel","year":"2019","journal-title":"JBMR Plus"},{"issue":"10189","key":"10.1016\/j.lana.2021.100131_bib0009","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"journal-title":"Krzywica Hipofosfatemiczna- ORPHA437","year":"2012","author":"J\u00fcppner","key":"10.1016\/j.lana.2021.100131_bib0010"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0538-4","article-title":"Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia","volume":"11","author":"Forestier-Zhang","year":"2016","journal-title":"Orphanet J Rare Dis"},{"journal-title":"Pharmacoeconomic Review Report - Burosumab","article-title":"The Canadian Agency for Drugs and Technologies in Health (CADTH)","year":"2020","key":"10.1016\/j.lana.2021.100131_bib0012"},{"key":"10.1016\/j.lana.2021.100131_bib0013","series-title":"Organization WH","first-page":"226","article-title":"Basic epidemiology","author":"Bonita","year":"2006"},{"issue":"211","key":"10.1016\/j.lana.2021.100131_bib0014","first-page":"93","article-title":"Medidas de frecuencia, asociaci\u00f3n e impacto en investigaci\u00f3n aplicada","volume":"54","author":"Mir\u00f3n Canelo","year":"2008","journal-title":"Med Segur Trab (Madr)"},{"journal-title":"Ley 1751 de 2015. Por Medio de La Cual Se Regula El Derecho Fundamental a La Salud y Se Dictan Otras Disposiciones","year":"2015","key":"10.1016\/j.lana.2021.100131_bib0015"},{"journal-title":"Ley 1438 Del 19 de Enero de 2011: Por Medio de La Cual Se Reforma El Sistema General de Seguridad Social En Salud y Se Dictan Otras Disposiciones","year":"2011","key":"10.1016\/j.lana.2021.100131_bib0016"},{"year":"2005","series-title":"Handbook of Health Research Methods: Investigation, Measurement and Analysis","author":"Bowling","key":"10.1016\/j.lana.2021.100131_bib0017"},{"key":"10.1016\/j.lana.2021.100131_bib0018","unstructured":"Orphanet. Prevalencia de las enfermedades raras : Datos bibliogr\u00e1ficos. In: Nguengang Wakap S, ed. Informes Peri\u00f3dicos de Orphanet, Serie Enfermedades Raras. Joint Action; update 2021:13 24. Accessed November 12, 2017."},{"issue":"5","key":"10.1016\/j.lana.2021.100131_bib0019","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.lana.2021.100131_bib0020","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e74","article-title":"Estimating Lifetime Duration of Diabetes by Age and Gender in the Korean Population Using a Markov Model","volume":"34","author":"Cho","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147533","article-title":"Study of disease progression and relevant risk factors in diabetic foot patients using a multistate continuous-time Markov chain model","volume":"11","author":"Begun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lana.2021.100131_bib0022","unstructured":"Barendregt J, World Health Organization. WHO | Software tools. Health statistics and information systems ."},{"issue":"11","key":"10.1016\/j.lana.2021.100131_bib0023","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pds.1660","article-title":"Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model","volume":"17","author":"Villaverde-Hueso","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lana.2021.100131_bib0024","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2012008","article-title":"Burden of Disease of Multiple Sclerosis in Korea","volume":"34","author":"Chung","year":"2012","journal-title":"Epidemiol Health"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5582\/irdr.2015.01015","article-title":"Using inpatient data to estimate the prevalence of Wegener's granulomatosis in China","volume":"5","author":"Liu","year":"2016","journal-title":"Intractable Rare Dis Res"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-7954-1-4","article-title":"A generic model for the assessment of disease epidemiology: The computational basis of DisMod II","volume":"1","author":"Barendregt","year":"2003","journal-title":"Popul Health Metr"},{"journal-title":"Estad\u00edsticas Vitales de Colombia","article-title":"Departamento Administrativo Nacional de Estad\u00edstica (DANE","year":"2018","key":"10.1016\/j.lana.2021.100131_bib0027"},{"issue":"5\/6","key":"10.1016\/j.lana.2021.100131_bib0028","first-page":"442","article-title":"Progresos en eSalud en Colombia\u00a0: adopci\u00f3n del Sistema de Informaci\u00f3n Nacional en C\u00e1ncer","volume":"35","author":"Rivillas Garc\u00eda","year":"2014","journal-title":"Rev Panam salud p\u00fablica"},{"issue":"2","key":"10.1016\/j.lana.2021.100131_bib0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lana.2021.100131_bib0030","first-page":"207","article-title":"Calvo P\u00e1ramo E CC. Osteomalacia y raqu\u00edtismo. An\u00e1lisis y estudio en diferentes periodos historicos en Colombia","volume":"9","author":"Iglesias Gamarra","year":"2000","journal-title":"REEMO"},{"issue":"2","key":"10.1016\/j.lana.2021.100131_bib0031","first-page":"117","article-title":"Raquitismo hipofosfat\u00e9mico ligado al X (XLH): Presentaci\u00f3n de una familia, asociado a una osteoartritis prematura y simulando adem\u00e1s una espondiloartropat\u00eda seronegativa","volume":"15","author":"Quintana L\u00f3pez","year":"2008","journal-title":"Rev Colomb Reumatol"},{"key":"10.1016\/j.lana.2021.100131_bib0032","article-title":"En cauca, caso \u00fanico en el mundo de raquitismo","author":"Tiempo","year":"1991","journal-title":"El Tiempo - Archivo Digital de Noticias de Colombia y el Mundo desde 1.990"},{"journal-title":"Orphanet Portal de informaci\u00f3n de enfermedades raras y medicamentos hu\u00e9rfanos","article-title":"Orphanet. Raquitismo hipofosfat\u00e9mico autos\u00f3mico dominante","year":"2019","key":"10.1016\/j.lana.2021.100131_bib0033"},{"journal-title":"Orphanet Portal de informaci\u00f3n de enfermedades raras y medicamentos hu\u00e9rfanos","article-title":"Orphanet. Raquitismo hipofosfat\u00e9mico hereditario con hipercalciuria","year":"2019","key":"10.1016\/j.lana.2021.100131_bib0034"},{"journal-title":"Orphanet Portal de informaci\u00f3n de enfermedades raras y medicamentos hu\u00e9rfanos","article-title":"Orphanet. Hipofosfatemia ligada al X","year":"2019","key":"10.1016\/j.lana.2021.100131_bib0035"},{"issue":"1","key":"10.1016\/j.lana.2021.100131_bib0036","first-page":"22","article-title":"Raquitismo Renal Hipofosfat\u00e9mico: Experiencia en 10 A\u00f1os","volume":"67","author":"Sakihara Asato","year":"2014","journal-title":"Rev peru pediatr"},{"issue":"3","key":"10.1016\/j.lana.2021.100131_bib0037","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","article-title":"Incidence and prevalence of nutritional and hereditary rickets in southern Denmark","volume":"160","author":"Beck-Nielsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lana.2021.100131_bib0038","series-title":"World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018)","first-page":"S277","article-title":"X-linked hypophosphataemia: burden of disease using United Kingdom primary care data","volume":"29","author":"Javaid","year":"2018"},{"issue":"3","key":"10.1016\/j.lana.2021.100131_bib0039","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1210\/clinem\/dgz203","article-title":"Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis","volume":"105","author":"Hawley","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lana.2021.100131_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.gde.2016.09.003","article-title":"Admixture in Latin America","volume":"41","author":"Adhikari","year":"2016","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.lana.2021.100131_bib0041","article-title":"Impact on Health and Counseling- Training Course in Sexual and Reproductive Health Research","author":"Hamamy","year":"2015","journal-title":"Consanguineous Marriages Trends"},{"key":"10.1016\/j.lana.2021.100131_bib0042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000022956","article-title":"Consanguinity in South America: Demographic aspects","volume":"51","author":"Liascovich","year":"2001","journal-title":"Hum Hered"},{"issue":"4","key":"10.1016\/j.lana.2021.100131_bib0043","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1590\/S0004-27302006000400025","article-title":"Hypophosphatemic rickets and osteomalacia","volume":"50","author":"De Menezes Filho","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.lana.2021.100131_bib0044","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia-aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lana.2021.100131_bib0045","article-title":"The portal for rare diseases and orphan drugs","author":"Cesca","year":"2019","journal-title":"Oncogenic osteomalacia"},{"issue":"2","key":"10.1016\/j.lana.2021.100131_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00590-014-1496-y","article-title":"Hypophosphatemic rickets: etiology, clinical features and treatment","volume":"25","author":"Pavone","year":"2015","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1016\/j.lana.2021.100131_bib0047","article-title":"Orphanet:The portal for rare diseases and orphan drugs","author":"Chapurlat","year":"2021","journal-title":"Fibrous dysplasia of bone"},{"key":"10.1016\/j.lana.2021.100131_bib0048","article-title":"Orphanet:The portal for rare diseases and orphan drugs","author":"Walsh","year":"2021","journal-title":"Fanconi syndrome"},{"key":"10.1016\/j.lana.2021.100131_bib0049","article-title":"National Organization for Rare Disorders (NORD)","author":"Carpenter","year":"2019","journal-title":"Familial Hypophosphatemia Rare disease database"},{"article-title":"World Health Organization","year":"2018","series-title":"Releases new International Classification of Diseases (ICD 11)","key":"10.1016\/j.lana.2021.100131_bib0050"},{"journal-title":"Imprenta Nacional","article-title":"Colombia. Ministerio de Salud y Protecci\u00f3n Social. Direcci\u00f3n de Epidemiolog\u00eda y Demograf\u00eda. Sistema Nacional de Estudios y Encuestas Poblacionales Para La Salud","year":"2013","key":"10.1016\/j.lana.2021.100131_bib0051"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X21001277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X21001277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:48:09Z","timestamp":1757404089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X21001277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":51,"alternative-id":["S2667193X21001277"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2021.100131","relation":{},"ISSN":["2667-193X"],"issn-type":[{"type":"print","value":"2667-193X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2021.100131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100131"}}